The Consequences of ‘Brexit’ for Drug Discovery and Development, and the Regulatory Implications
Expert Opinion on Drug Discovery - United Kingdom
doi 10.1080/17460441.2018.1463215
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 15, 2018
Authors
Publisher
Informa UK Limited